institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published San Jose, United StatesUpdated

HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results

Summary by citybuzz.co
HeartBeam Inc. (NASDAQ: BEAT) has announced its financial results and operational highlights for the first quarter of 2025, showcasing significant strides toward the commercialization of its groundbreaking 12-lead ECG synthesis software. The company’s VALID-ECG pivotal study achieved a 93.4% diagnostic agreement with standard ECGs, a milestone that underscores the potential of HeartBeam’s technology to revolutionize cardiac care outside traditio…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

citybuzz.co broke the news in on Friday, June 13, 2025.
Sources are mostly out of (0)

You have read 2 out of your 5 free daily articles.

Our use of cookies
Unlike other news sites, we do not share or sell your data to third-parties for targeted ads.
By continuing to use our application or website, you agree to our Terms of Service and Privacy Policy.